Full Length Article
Therapeutic potential of Hyoscyamus niger-derived compounds: Targeting ovarian cancer through antioxidant activity and EGFR tyrosine kinase inhibition
Year: 2024, Volume: 36, Issue: 3, March
Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.